178 related articles for article (PubMed ID: 17874571)
21. The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients.
Inoue T; Nakamura T; Katsuma A; Masumoto S; Minami E; Katagiri D; Hoshino T; Shibata M; Tada M; Hinoshita F
Nephrol Dial Transplant; 2009 Jul; 24(7):2252-7. PubMed ID: 19218539
[TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Okimoto N; Matsushima T; Kageoka T; Oka M
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1422-6. PubMed ID: 19861017
[TBL] [Abstract][Full Text] [Related]
23. Utility of QuantiFERON-TB Gold in-tube testing for latent TB infection in HIV-infected individuals.
Jones S; de Gijsel D; Wallach FR; Gurtman AC; Shi Q; Sacks H
Int J Tuberc Lung Dis; 2007 Nov; 11(11):1190-5. PubMed ID: 17958980
[TBL] [Abstract][Full Text] [Related]
24. Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users.
Shah SS; McGowan JP; Klein RS; Converse PJ; Blum S; Gourevitch MN
Med Sci Monit; 2006 Apr; 12(4):MT11-6. PubMed ID: 16572060
[TBL] [Abstract][Full Text] [Related]
25. Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-γ release assay, and the development of active tuberculosis in HIV-seropositive persons.
Santin M; Casas S; Saumoy M; Andreu A; Moure R; Alcaide F; Ferrer E; Podzamczer D
Diagn Microbiol Infect Dis; 2011 Jan; 69(1):59-65. PubMed ID: 21146715
[TBL] [Abstract][Full Text] [Related]
26. Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test.
Brock I; Ruhwald M; Lundgren B; Westh H; Mathiesen LR; Ravn P
Respir Res; 2006 Apr; 7(1):56. PubMed ID: 16579856
[TBL] [Abstract][Full Text] [Related]
27. [Results of repeated QFT-2G checkings at two-year interval and their comparison with TST results introduced into infection control program for staffs working at a hospital with isolation wards for tuberculosis].
Nakajima Y; Ogata H; Yoshiyama T; Mitarai S; Harada N; Higuchi K; Mori T
Kekkaku; 2008 Jun; 83(6):445-50. PubMed ID: 18634448
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection.
Harada N; Higuchi K; Yoshiyama T; Kawabe Y; Fujita A; Sasaki Y; Horiba M; Mitarai S; Yonemaru M; Ogata H; Ariga H; Kurashima A; Wada A; Takamori M; Yamagishi F; Suzuki K; Mori T; Ishikawa N
J Infect; 2008 May; 56(5):348-53. PubMed ID: 18395264
[TBL] [Abstract][Full Text] [Related]
29. Interferon-gamma release assay for diagnosing Mycobacterium tuberculosis infections in patients with systemic lupus erythematosus.
Takeda N; Nojima T; Terao C; Yukawa N; Kawabata D; Ohmura K; Usui T; Fujii T; Ito Y; Iinuma Y; Mimori T
Lupus; 2011 Jul; 20(8):792-800. PubMed ID: 21562022
[TBL] [Abstract][Full Text] [Related]
30. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country.
Vanini V; Petruccioli E; Gioia C; Cuzzi G; Orchi N; Rianda A; Alba L; Giancola ML; Conte A; Schininà V; Rizzi EB; Girardi E; Goletti D
J Infect; 2012 Jul; 65(1):49-59. PubMed ID: 22465752
[TBL] [Abstract][Full Text] [Related]
31. [Cost-effectiveness analysis of QuantiFERON-TB 2nd generation used for detection of tuberculosis infection in contact investigations].
Mori T; Harada N
Kekkaku; 2005 Nov; 80(11):675-86. PubMed ID: 16363672
[TBL] [Abstract][Full Text] [Related]
32. [Usefulness of QuantiFERON TB-2G in contact investigation of a tuberculosis outbreak in a university].
Funayama K; Tsujimoto A; Mori M; Yamamoto H; Fujiwara K; Nishimura T; Hasegawa N; Horiguchi I; Mori T; Marui E
Kekkaku; 2005 Jul; 80(7):527-34. PubMed ID: 16167779
[TBL] [Abstract][Full Text] [Related]
33. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
[TBL] [Abstract][Full Text] [Related]
34. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P
Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
[TBL] [Abstract][Full Text] [Related]
35. Transitional changes in T-cell responses to Mycobacterium tuberculosis-specific antigens during treatment.
Kobashi Y; Mouri K; Yagi S; Obase Y; Miyashita N; Oka M
J Infect; 2009 Mar; 58(3):197-204. PubMed ID: 18848730
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal observation of an interferon gamma-released assay (T-SPOT.TB) for Mycobacterium tuberculosis infection in AIDS patients on highly active antiretroviral therapy.
Zhang LF; Liu XQ; Zuo LY; Li TS; Deng GH; Wang AX
Chin Med J (Engl); 2010 May; 123(9):1117-21. PubMed ID: 20529548
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
French M; Keane N; McKinnon E; Phung S; Price P
HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
[TBL] [Abstract][Full Text] [Related]
38. False negative results of QuantiFERON TB-2G test in patients with active tuberculosis.
Kobashi Y; Shimizu H; Ohue Y; Mouri K; Obase Y; Miyashita N; Oka M
Jpn J Infect Dis; 2009 Jul; 62(4):300-2. PubMed ID: 19628910
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of cut-off values of interferon-gamma-based assays in the diagnosis of M. tuberculosis infection.
Soysal A; Torun T; Efe S; Gencer H; Tahaoglu K; Bakir M
Int J Tuberc Lung Dis; 2008 Jan; 12(1):50-6. PubMed ID: 18173877
[TBL] [Abstract][Full Text] [Related]
40. Acute effect of low-flux hemodialysis process on the results of the interferon-gamma-based QuantiFERON-TB Gold In-Tube test in end-stage renal disease patients.
Hursitoglu M; Cikrikcioglu MA; Tukek T; Beycan I; Ahmedova N; Karacuha S; Sansal M; Ozkan O; Celik V
Transpl Infect Dis; 2009 Feb; 11(1):28-32. PubMed ID: 18803615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
